Luca A. Ramenghi
Distinguished in Intraventricular Hemorrhage of the Newborn

Luca A. Ramenghi

Genoa, IT 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Intraventricular Hemorrhage of the Newborn
Genoa, IT 
OverviewLocationsClinical Research

Overview

Luca Ramenghi practices in Genoa, Italy. Mr. Ramenghi is rated as a Distinguished expert by MediFind in the treatment of Intraventricular Hemorrhage of the Newborn. His top areas of expertise are Intraventricular Hemorrhage of the Newborn, Premature Infant, Infant Respiratory Distress Syndrome, and Retinopathy of Prematurity.

His clinical research consists of co-authoring 177 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 17 articles and participated in 2 clinical trials in the study of Intraventricular Hemorrhage of the Newborn.

Gender
Male

Locations

Genoa, 16147, Italy
Other Locations
Milan, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 Compared to Standard Neonatal Care for the Prevention of Bronchopulmonary Dysplasia, the Most Common Cause of Chronic Lung Disease of Prematurity
Enrollment Status: Recruiting
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drug: SHP607
Study Phase: Phase 2
Long-Term Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Long-Term Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely Premature Infants
Enrollment Status: Terminated
Publish Date: March 24, 2023
Intervention Type: Other
View 1 Less Clinical Trial

177 Total Publications

Uncertainty in brain imaging after therapeutic hypothermia.
Uncertainty in brain imaging after therapeutic hypothermia.
Journal: The Lancet. Child & adolescent health
Published: July 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ramenghi's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 41 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile